Deal #101 - IPO Pulmonx Corp (LANG) -make money on the treatment
Stock market. Stocks. IPO Pulmonx Corp (LUNG) — on October 01, 2020, trading in shares of the company that developed the Zephyr technology will begin on the American stock exchange (the deadline for submitting an application for participation with a broker is 20-00 Moscow time on 29.09.2020). A special device is placed in the airway to treat severe emphysema. The placement is underwritten by BofA Securities and Morgan Stanley.
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)
2% of the Fund will be invested in shares of this company. Detailed reports on our paid subscription for all partners will be provided in PDF (additional data on request in PM)